ACTU vs APTV · $49.0M cap vs P/E 41, rev $19.71B
Actuate Therapeutics, Inc. Common stock (ACTU) versus Aptiv PLC (APTV) — a side-by-side from cached financials, not a winner call.
Actuate Therapeutics, Inc. Common stock (ACTU) is a biotechnology company listed on NASDAQ.
Aptiv PLC (APTV) is a auto parts company listed on US.
ACTU does not have a complete income-statement cache yet.
Latest reported APTV revenue for 2024-12-31 was $19.71B. Net income was $275.0M. Revenue was down 1.7% from 2023-12-31 to 2024-12-31. APTV currently screens at market cap $14.52B and trailing P/E 40.8.
ACTU currently screens at market cap $49.0M. APTV currently screens at market cap $14.52B and trailing P/E 40.8.
Not investment advice. Open the ACTU and APTV stock pages for the full models.
Not investment advice.